Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

FUE is a versatile hair transplant technique with many uses and good outcomes when performed with skill.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Mutations in the AR gene cause hair thinning and loss.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Nutraceuticals can effectively manage hormonal imbalances and related health issues.

Future clinical uses of Intense Pulsed Light (IPL) are likely to grow and become more effective with new advancements and combined treatments.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

New treatments for alopecia areata show promise, but standardized guidelines are needed.